Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.
about
Peripheral cannabinoid receptor, CB2, regulates bone mass.Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells.The CB2 receptor and its role as a regulator of inflammationPalmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cellsInvolvement of cannabinoids in the cardioprotection induced by lipopolysaccharideInhibitory effect of palmitoylethanolamide on gastrointestinal motility in miceThe endocannabinoid system: 'NO' longer anonymous in the control of nitrergic signalling?Endocannabinoid signalling in innate and adaptive immunity.Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.Regulation of MMP-9 by a WIN-binding site in the monocyte-macrophage system independent from cannabinoid receptors.Endocannabinoids and immune regulation.Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems.Cannabinoids and neuroinflammation.Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner.Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusionsEvaluation of fatty acid amides in the carrageenan-induced paw edema model.The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitisCannabinoid receptor 2 protects against acute experimental sepsis in miceFatty acid amide signaling molecules.The anti-inflammatory compound palmitoylethanolamide inhibits prostaglandin and hydroxyeicosatetraenoic acid production by a macrophage cell linePalmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism.Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide.The neuroprotective properties of palmitoylethanolamine against oxidative stress in a neuronal cell line.Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o /RhoA/ROCK signaling pathway.Delay of morphine tolerance by palmitoylethanolamide.Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: an in vitro studyEffect of palmitoylethanolamide on inflammatory and neuropathic pain in ratsRole of endogenous cannabinoids in ischemia/reperfusion injury following testicular torsion in rats.Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections.Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents.Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model.Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice
P2860
Q24536360-94CA34D7-91E0-4292-966F-4A0D9AE9932AQ24630453-24B85F15-3915-4430-B5AD-0943D5C1B666Q28066700-47AF8B37-1A25-4C4B-931C-50323F2D95F5Q28345246-A5E94471-0C8D-4B77-AE73-2C240619B1FEQ28349586-12937165-0DFA-46C7-9E2D-81251D00C800Q28362696-7F734538-71BD-4FC8-9990-8299D17E4A07Q33712156-E9B56899-E86C-427E-BEE4-A2961D6590EBQ34458059-3C3317E0-6457-41D2-B6DB-0272D52553BFQ34471868-2EDAD78B-FCF5-4C76-AFEB-413AE3EAA278Q34471928-6FB7BBF0-3C01-4D6E-BEE0-4D66620C006BQ34607419-39536953-4CD6-4357-BEED-03D9568AF6D0Q35044663-0F4C5E5F-8108-4226-BCCC-A60AB9C0119EQ35046205-EBBF67AB-1A27-410A-A8A5-FD8EFB87357FQ36027964-B4994ADA-A778-4D79-8CFC-93297E0E80D7Q36052772-DF736452-45DF-442B-862B-A6F1BE90CE39Q36384547-FFF7C8A2-F518-453B-A671-5EE1DEF9ACB3Q36784020-A2B93D58-E9FC-45AE-9D76-65B83EFD7B30Q36921431-C76D04BB-DD3B-4AEA-B20D-4BC30F935A18Q37785382-C7B0812B-31E9-48F7-BF32-752B1B0D4C85Q38709659-497D90E8-5C1D-4C08-B19A-643C1D2464EBQ39230043-8F7BF7BE-0EA6-450D-809F-1336FEF4B2F1Q39467487-4CB8CEB5-7A81-483E-BAE9-1C3015FDBB9AQ39764744-EF677154-7908-4B10-8D57-A019A6C27F92Q40594444-4047F2C2-01BC-4C58-B6DA-DD59BF6705D6Q41643613-0BBB1450-016C-49B4-B01B-1FCC495AE59FQ41908176-8F457A54-65F2-45BF-A163-65AA0E737948Q41912809-C53E97DE-9E99-411D-A709-FD6E377799BDQ42324388-5DEFE7BC-FD9E-4F50-A883-B4514B4E2BB4Q42379739-C02F898A-A218-4CA0-8E3B-87F40AA93AC3Q42435550-726780AE-7683-435B-B6E5-0F97CA463E38Q42719351-10EB8568-B2A4-4ED8-8D89-7924AFD66C46Q43263256-37E7B284-F7F6-434E-B198-1B56306CC7E9Q44304365-05303F12-DF3A-46E5-BC5F-536A9A96CF10Q47655490-47B42194-DC0A-44CF-801E-B9EB3357AF2AQ58331887-C36614D8-50E6-493D-B1F4-8C7812E43315
P2860
Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inhibition of nitric oxide pro ...... ids and palmitoylethanolamide.
@ast
Inhibition of nitric oxide pro ...... ids and palmitoylethanolamide.
@en
type
label
Inhibition of nitric oxide pro ...... ids and palmitoylethanolamide.
@ast
Inhibition of nitric oxide pro ...... ids and palmitoylethanolamide.
@en
prefLabel
Inhibition of nitric oxide pro ...... ids and palmitoylethanolamide.
@ast
Inhibition of nitric oxide pro ...... ids and palmitoylethanolamide.
@en
P1476
Inhibition of nitric oxide pro ...... oids and palmitoylethanolamide
@en
P2093
P304
P356
10.1016/S0014-2999(00)00437-4
P407
P577
2000-08-01T00:00:00Z